Lyka Labs Share Price

₹ 75.57

+₹0.50 (0.67%)

Last updated 03 Nov, 2026, 11:14 IST

NSE: LYKALABS

Lyka Labs Share Price Today

As of 3 Nov 2026, Lyka Labs share price is ₹75.57. The stock opened at ₹75.57, compared to its previous close of ₹75.07. During today's trading session, Lyka Labs share price moved in the range of ₹75.57 to ₹75.57, with an average price of ₹75.57 for the day. Looking at its last 52-week, the stock has touched a low of ₹44.10 and a high of ₹96.00. On the performance front, Lyka Labs share price has increased by 25.75% over the last six months and is down 20.17% on a year-on-year basis.

₹75.57

0.67% up today

₹75.57

1D LOW

1D HIGH

Lyka Labs Stock Insights

Latest Earning

Op Profit TrendUp by 122.70% QoQ

Latest Earning

Net Profit TrendUp by 125.40% QoQ

Latest Earning

Revenue TrendUp by 49.20% QoQ

Stock Performance

OutperformingBeat Nifty by 31.45 % in last 3 month

Shareholding Pattern

DIIDII decreased stake by 0.02%

Shareholding Pattern

FIIFII decreased stake by 8.18%

Lyka Labs Stock Insights

Latest Earning

Op Profit TrendUp by 122.70% QoQ

Latest Earning

Net Profit TrendUp by 125.40% QoQ

Latest Earning

Revenue TrendUp by 49.20% QoQ

Stock Performance

OutperformingBeat Nifty by 31.45 % in last 3 month

Shareholding Pattern

DIIDII decreased stake by 0.02%

Shareholding Pattern

FIIFII decreased stake by 8.18%

Lyka Labs stock performance
Open	₹75.57
High	₹75.57
Low	₹75.57
Prev. close	₹75.07

Lyka Labs trading activity
Volume	968
Average traded price	₹75.57
Last traded time	11:14:30 03 Nov
Last traded quantity	255

₹73.57₹76.57

Circuit Low

Circuit High

₹44.10₹96.00

52-Week Low

52-Week High

Circuit

₹73.57

₹76.57

52-week

₹44.10

₹96.00

Mkt Cap Cr

272.95

P/E

-29.62

P/B

3.0

ROA

-2.69%

ROE

-4.44%

ROCE

-1.54%

Quick Ratio

0.92

EV/EBITDA

53.36

Mkt Cap Cr

272.95

P/E

-29.62

P/B

3.0

ROA

-2.69%

ROE

-4.44%

ROCE

-1.54%

Quick Ratio

0.92

EV/EBITDA

53.36

Based on fundamentals, this stock's

Performance

Very Poor

Lyka Labs has not beaten FD return of 7%

Valuation

Overvalued

Lyka Labs appears overvalued compared to its peers

Earnings

Neutral

Lyka Labs earnings growth is positive

Peer Comparison

Peer comparison — key ratios
Name	Mkt Cap Cr	P/E	P/B	ROA	ROE	ROCE	Quick Ratio	EV/EBITDA
Sun Pharmaceutical Industries	4,26,661.74	38.83	4.78	9.61%	13.79%	18.65%	2.31	22.27
Divis Laboratories	2,57,902.73	88.17	15.39	14.6%	15.32%	19.56%	3.5	58.97
Torrent Pharmaceuticals	1,74,402.47	83.09	9.49	4.7%	11.42%	11.37%	0.75	33.6
Laurus Labs	1,26,811.28	95.17	20.92	11.58%	22.11%	20.91%	0.68	54.77
Zydus Lifesciences	1,24,089.48	27.02	4.58	8.57%	18.59%	17.35%	0.91	16.42
Dr. Reddy's Laboratories	1,12,698.53	40.84	2.9	4.79%	7.21%	8.58%	1.35	19.05
Cipla	1,11,486.14	39.06	3.15	6.6%	8.18%	10.8%	2.5	21.03
Mankind Pharma	1,02,195.62	45.15	5.81	7.82%	12.76%	14.68%	0.74	25.01
Aurobindo Pharma	96,536.90	26.02	2.55	6.34%	9.25%	11.76%	1.15	12.38
Lupin	91,870.16	16.45	4.07	14.47%	23.76%	24.88%	1.42	9.83

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

Lyka Labs Company Background

ISIN

INE933A01014

Sector Market Cap

₹ 272.95 Cr

Lyka Labs Limited is an India-based pharmaceutical company engaged in the development, manufacture and marketing of quality finished dosages. The Company manufactures pharmaceutical products such as Dry Powder, Liquid, Lyophilized Injections and External Preparations for several International Markets and the Domestic Market. The Company’s R&D is engaged in the development of new formulations and has developed several products in the categories, such as Injectables: Lyophilized Injection, Liquid Injections & Dry Powder Injections, and Topical Preparation: Ointment /Creams and Lotions. It offers formulations, such as emollient, anti-aging, cleansing lotion, hair care products, anti-dandruff shampoo, sunscreen, anti-acne, antioxidant tablets, antioxidants combination, proton pump inhibitor, antifungal, anti-malarial, antibacterial, corticosteroid hormones and cephalosporins. The Company's subsidiaries include Lyka BDR International Limited and Lyka Exports Limited.

Lyka Labs Financial Highlights

Revenue: Lyka Labs reported revenue of ₹131.94 crore in FY26 vs ₹140.73 crore in FY25. It showed a decrease of 6.25% on a yearly basis.
Operating Profit: Lyka Labs reported an operating loss of ₹11.78 crore in FY26 vs ₹11.12 crore in FY25. It showed a decrease of 205.94% on a year-on-year basis.
Net Profit: Lyka Labs reported a net loss of ₹10.44 crore in FY26 vs ₹7.93 crore in FY25. It showed a decrease of 231.65% on a yearly basis.

Lyka Labs Quarterly Result Highlights

Lyka Labs reported revenue of ₹42.73 crore in Jun 2026, compared with ₹28.64 crore in Mar 2026, representing an increase of 49.20% on a quarter-on-quarter (QoQ) basis.
Lyka Labs reported an operating profit of ₹1.95 crore in Jun 2026, compared with ₹8.59 crore in Mar 2026, representing an increase of 122.70% on a quarter-on-quarter (QoQ) basis.
Lyka Labs reported a profit of ₹2.05 crore in Jun 2026, compared with ₹8.07 crore in Mar 2026, reflecting an increase of 125.40% on a QoQ basis.
The earnings per share (EPS) of Lyka Labs stood at ₹2.81 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Promoters

58.45%

FII

0.15%

Other DII

0.65%

Retail and other

40.73%

Mutual funds

0.01%

Foreign Institutional Investor (FII)

FII shareholding by period
Dec 2025	0.17%
Mar 2026	0.29%
Jun 2026	0.17%
Sep 2026	0.15%

Lyka Labs Investment Returns

1 day

-2.00%

1 week

-6.15%

1 month

-7.95%

1 year

-20.17%

3 years

-31.54%

5 years

-27.43%

Lyka Labs Share Price History

Lyka Labs share price history by day, showing open and close prices and the percentage change
Day	Open / Close	Change %
02 Nov 26	₹76.00 / ₹75.07	-2.00%
30 Oct 26	₹77.77 / ₹76.60	+0.46%
29 Oct 26	₹77.42 / ₹76.25	-1.51%
28 Oct 26	₹79.00 / ₹77.42	-2.00%
27 Oct 26	₹79.99 / ₹79.00	-1.24%
26 Oct 26	₹80.00 / ₹79.99	-1.23%
23 Oct 26	₹80.99 / ₹80.99	-2.00%
22 Oct 26	₹82.64 / ₹82.64	-1.99%
21 Oct 26	₹84.32 / ₹84.32	-2.00%
19 Oct 26	₹86.04 / ₹86.04	-1.99%

Lyka Labs Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
Particulars	Mar 2026	Mar 2025	Mar 2024	Mar 2023
Revenue	₹128.44	₹138.50	₹111.19	₹93.07
Other Income	₹3.50	₹2.23	₹1.45	₹3.40
Total Revenue	₹131.94	₹140.73	₹112.65	₹96.47
Total Expenses	₹143.72	₹129.60	₹113.17	₹102.25
Profit Before Tax	-₹11.78	₹11.12	-₹0.93	-₹13.17
Tax	-₹1.34	₹3.19	₹1.69	-₹0.02
Profit After Tax	-₹10.44	₹7.93	-₹2.62	-₹13.15
EPS - Basic	-₹2.81	₹2.22	-₹0.79	-₹4.63
EPS - Diluted	-₹2.81	₹2.22	-₹0.79	-₹4.63

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
Particulars	Mar 2026	Mar 2025	Mar 2024	Mar 2023
Profit before tax	-₹11.78	₹11.12	-₹0.93	-₹13.17
Income before WC changes	₹8.05	₹19.59	₹17.09	₹18.61
Change in Assets	-₹3.07	-₹17.36	-₹14.31	₹1.70
Change in Liabilities	₹0.57	₹2.71	₹0.51	-₹11.56
Change in WC	-₹2.50	-₹14.65	-₹13.80	-₹9.86
Cash flow from Operations	₹5.24	₹1.90	₹1.77	₹8.95
Cash flow from Investing	-₹9.41	-₹11.80	-₹9.49	₹7.35
Cash flow from Financing	₹4.19	₹5.29	₹1.95	-₹21.64
Total Cash Flow	₹0.02	-₹4.60	-₹5.76	-₹5.34
Cash (Start of the year)	₹1.34	₹5.95	₹11.71	₹17.05
Cash (End of the year)	₹1.36	₹1.34	₹5.95	₹11.71

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
Particulars	Mar 2026	Mar 2025	Mar 2024	Mar 2023
Non-Current Assets	₹111.26	₹108.77	₹106.07	₹107.32
Current Assets	₹63.28	₹67.43	₹50.65	₹44.20
Total Assets	₹174.54	₹176.20	₹156.72	₹151.52
Current Liabilities	₹53.90	₹46.63	₹37.64	₹32.60
Net Current Asset	₹9.38	₹20.80	₹13.01	₹11.61
Non-Current Liabilities	₹29.81	₹25.99	₹50.82	₹73.25
Equity Capital	₹90.83	₹103.58	₹68.27	₹45.67
Total Equity & Liabilities	₹174.54	₹176.20	₹156.72	₹151.52

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
Particulars	Mar 2026	Mar 2025	Mar 2024	Mar 2023
Revenue	₹120.91	₹134.70	₹106.40	₹80.59
Other Income	₹3.97	₹2.76	₹1.65	₹3.45
Total Revenue	₹124.88	₹137.46	₹108.04	₹84.04
Total Expenses	₹135.10	₹126.36	₹108.92	₹90.08
Profit Before Tax	-₹33.24	₹11.10	-₹0.93	-₹13.21
Tax	-₹0.95	₹3.18	₹1.34	₹0.08
Profit After Tax	-₹32.29	₹7.92	-₹2.27	-₹13.29
EPS - Basic	-₹9.05	₹2.19	-₹0.72	-₹4.65
EPS - Diluted	-₹9.05	₹2.19	-₹0.72	-₹4.65

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
Particulars	Mar 2026	Mar 2025	Mar 2024	Mar 2023
Profit before tax	-₹33.24	₹11.10	-₹0.93	-₹13.21
Income before WC changes	₹8.34	₹19.10	₹15.72	₹18.10
Change in Assets	-₹4.80	-₹20.25	-₹12.62	-₹2.61
Change in Liabilities	₹2.02	₹2.57	₹1.45	-₹8.20
Change in WC	-₹2.78	-₹17.68	-₹11.16	-₹10.81
Cash flow from Operations	₹5.09	-₹1.62	₹3.09	₹6.87
Cash flow from Investing	-₹9.42	-₹11.22	-₹8.61	₹6.77
Cash flow from Financing	₹4.19	₹8.25	₹2.71	-₹20.33
Total Cash Flow	-₹0.14	-₹4.59	-₹2.81	-₹6.69
Cash (Start of the year)	₹1.33	₹5.91	₹8.70	₹15.38
Cash (End of the year)	₹1.19	₹1.33	₹5.89	₹8.70

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
Particulars	Mar 2026	Mar 2025	Mar 2024	Mar 2023
Non-Current Assets	₹110.29	₹122.53	₹136.15	₹136.56
Current Assets	₹60.45	₹70.15	₹49.86	₹42.30
Total Assets	₹170.75	₹192.68	₹186.02	₹178.86
Current Liabilities	₹53.50	₹45.06	₹35.91	₹29.97
Net Current Asset	₹6.95	₹25.09	₹13.95	₹12.33
Non-Current Liabilities	₹30.25	₹26.01	₹50.78	₹72.46
Equity Capital	₹87.00	₹121.60	₹99.33	₹76.43
Total Equity & Liabilities	₹170.75	₹192.68	₹186.02	₹178.86